ECO PCO-RL: E2408 3-Arm Randomized Phase II Trial of Bendamustine -Rituximab (BR) followed by Rituximab vs Bortezomib-BR (BVR)...

Yang, Ximing J (PD/PI)

Pathology

Project: Research project

Status	Finished
Effective start/end date	12/13/10 → 12/12/14

Funding

Frontier Science and Technology Research Foundation (PCO2408C-00 // PCO2408C-00)
Celgene Corporation (PCO2408C-00 // PCO2408C-00)